Literature DB >> 15546064

Course and long-term treatment of schizophrenic psychoses.

H-J Möller1.   

Abstract

As there is a lack of clear biological correlates for most psychiatric disorders, follow-up studies regarding course, outcome and prognosis of psychiatric disorders play an important role in psychiatric research, especially in terms of validation of psychiatric diagnoses and other psychiatric concepts, such as the concept of negative symptoms. Long-term studies also have their place in the description and evaluation of first treatment procedures. The first part of this paper will describe some general aspects of the long-term course and outcome of schizophrenic psychoses. The problem of relapses and relapse prevention will then be discussed. Especially data from recent studies will be considered in this overview.

Entities:  

Mesh:

Year:  2004        PMID: 15546064     DOI: 10.1055/s-2004-832666

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  8 in total

1.  Identification of targeted analyte clusters for studies of schizophrenia.

Authors:  Tammy M K Cheng; Yu-En Lu; Paul C Guest; Hassan Rahmoune; Laura W Harris; Lan Wang; Dan Ma; Victoria Stelzhammer; Yagnesh Umrania; Matt T Wayland; Pietro Lió; Sabine Bahn
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

2.  Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study.

Authors:  Josef Bäuml; Gabriele Pitschel-Walz; Anja Volz; Sandra Lüscher; Michael Rentrop; Werner Kissling; Thomas Jahn
Journal:  Schizophr Bull       Date:  2016-03-08       Impact factor: 9.306

3.  The course and outcomes of episodic endogenous psychoses with juvenile onset (a follow-up study).

Authors:  V G Kaleda
Journal:  Neurosci Behav Physiol       Date:  2009-11

Review 4.  Psychoeducation: a basic psychotherapeutic intervention for patients with schizophrenia and their families.

Authors:  Josef Bäuml; Teresa Froböse; Sibylle Kraemer; Michael Rentrop; Gabriele Pitschel-Walz
Journal:  Schizophr Bull       Date:  2006-08-18       Impact factor: 9.306

Review 5.  Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.

Authors:  Hans-Jürgen Möller
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

Review 7.  Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Authors:  O D Howes; A Egerton; V Allan; P McGuire; P Stokes; S Kapur
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments.

Authors:  O D Howes; P Fusar-Poli; M Bloomfield; S Selvaraj; P McGuire
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.